The Patent Finder

Mondobiotech Laboratories AG

Also on record
Records under this name other than patents Mondobiotech Laboratories AG holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 5 of 5 · Back to Mondobiotech Laboratories AG

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,541,364Use of a octreotide as a therapeutic agent
Formerly held
Lapsed on the fee record
Ended Sep 24, 2017 · USPTO record
Lapsed on the fee recordEnded Sep 24, 2017USPTO record
US 8,349,805Use of Gonadorelin as a therapeutic agent
Formerly held
Lapsed on the fee record
Ended Jan 8, 2017 · USPTO record
Lapsed on the fee recordEnded Jan 8, 2017USPTO record
US 8,338,380Use of the peptide RFMWMR as a therapeutic agent
Formerly held
Lapsed on the fee record
Ended Dec 25, 2016 · USPTO record
Lapsed on the fee recordEnded Dec 25, 2016USPTO record
US 8,211,856Use of somatostatin-14 as a therapeutic agent
Formerly held
Lapsed on the fee record
Ended Jul 3, 2016 · USPTO record
Lapsed on the fee recordEnded Jul 3, 2016USPTO record
US 8,193,149Use of Peptide YY, alone or in combination with glucagon-like peptide, for use in medicine
Formerly held
Lapsed on the fee record
Ended Jun 5, 2016 · USPTO record
Lapsed on the fee recordEnded Jun 5, 2016USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited